Kartic Rajput, M.D., PH.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 W Hammer Ln, Stockton, CA 95209 Phone: 209-941-0371 Fax: 209-951-2469 |
Dr. Edward Michael Outlaw, MD Pain Medicine - Interventional Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 4505 Precissi Ln Ste A, Stockton, CA 95207 Phone: 209-425-3815 |
Dr. Ravi R Pankhaniya, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 10200 Trinity Pkwy, Suite 206, Stockton, CA 95219 Phone: 209-207-0555 Fax: 209-916-4900 |
News Archive
SinoFresh HealthCare Products, Inc. announced the recent successful initial pilot animal study of the SinoFresh Nasal Spray product for use in preventing and decreasing the severity of H1N1 ("swine flu") virus.
Researchers in the Oregon State University College of Science have taken a key step toward new drugs and vaccines for combating COVID-19 with a deep dive into one protein's interactions with SARS-CoV-2 genetic material.
A new, sharper picture of the nano-machine that translates our genetic program into proteins promises to help researchers explain how some types of antibiotics work and could lead to the design of better ones.
A new study by researchers from the University of Miami shows that maternal sensitivity may influence language development among children who go on to develop autism. Although parenting styles are not considered as a cause for autism, this report examines how early parenting can promote resiliency in this population.
Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China. Bridge Laboratories China is the leading contract research organization (CRO) in China providing western standard GLP-compliant toxicology services to pharmaceutical and biotech companies from around the world. With this acquisition, Pharmaron becomes the first integrated CRO in China supporting clients with drug discovery and development processes in support of IND filings. This strategic acquisition strengthens Pharmaron's leading position in the fast-growing, highly dynamic pharmaceutical CRO industry.
› Verified 4 days ago